The Department of Laboratory Animal Resources (DLAR) is responsible for laboratory animal care and use for 50 peer review funded PIs of Roswell Park Cancer Institute (RPCI). This resource provides specialized animal husbandry, veterinary medical care, animal health surveillance, diagnostic laboratory facilities, many research technical services and resources including genetically-defined mice, a surgical program and technician and faculty training in support of the > 150 IACUC-approved animal use protocols. Additional resource services include polyclonal antibody production in several species, inbred and immune-deficient rodent production. Additional resource services include polyclonal antibody production in several species, inbred and immune-deficient rodent production. Daily animal inventories, currently about 15,000 include a variety of rodent species, rabbits, dogs and farm animals. The Department has 40 members, 100 of whom have achieved certification through the animal Technician Certification Board (ATCB) of the American Association for Laboratory Animal Science (AALAS). The new, four-story 41,000 nsf vivarium is within the new MRC that bridges Carlton Street and is between the Cancer Cell Center with its animal resource and the Research Studies Center. The combination of the two animal holding units provides >52,000 nsf. All mice housed in the new resource are viral antibody free. The basis for the mouse husbandry program is individually ventilated microisolators. Racks are designed too house 108 cages, each ventilated with sterile air and equipped port access with a continuous supply of purified water. A portion of the resource has been designed for ABSL, 2/3 capability for use with rodents. Labs for work with gene knockout and transgenic technologies in mice are immediately adjacent to animal holding rooms. The contiguous Cancer Center Animal Resource is the site of the new 4.7 Tesla CCSG animal research MRI resource and a whole animal cesium irradiation unit. The operating budget is comprised of revenues from institutional sources (74%), chargebacks (13%) and the Cancer Center Support Grant (13%). Continued support through the CCSG will permit DLAR to prove standard of care. and use that meet or exceed applicable state and federal standards, accomplish pursuit of DLAR to prove standard of care and use that meet or exceed applicable state and federal standards, accomplish pursuit of external accreditation (AALACi) and furnish investigators with a comprehensive program for safe, appropriate and cost effective research animal use.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016056-25
Application #
6324622
Study Section
Project Start
2000-06-28
Project End
2001-04-30
Budget Start
Budget End
Support Year
25
Fiscal Year
2000
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Eng, Diana G; Kaverina, Natalya V; Schneider, Remington R S et al. (2018) Detection of renin lineage cell transdifferentiation to podocytes in the kidney glomerulus with dual lineage tracing. Kidney Int 93:1240-1246
Ling, Xiang; Wu, Wenjie; Fan, Chuandong et al. (2018) An ABCG2 non-substrate anticancer agent FL118 targets drug-resistant cancer stem-like cells and overcomes treatment resistance of human pancreatic cancer. J Exp Clin Cancer Res 37:240
Chung, Sejin; Vail, Paris J; Witkiewicz, Agnieszka K et al. (2018) Coordinately targeting cell cycle checkpoint functions in integrated models of pancreatic cancer. Clin Cancer Res :
Mohammadpour, Hemn; O'Neil, Rachel; Qiu, Jingxin et al. (2018) Blockade of Host ?2-Adrenergic Receptor Enhances Graft-versus-Tumor Effect through Modulating APCs. J Immunol 200:2479-2488
Hsu, Alice H; Lum, Michelle A; Shim, Kang-Sup et al. (2018) Crosstalk between PKC? and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Rep 24:655-669
Sandlesh, Poorva; Juang, Thierry; Safina, Alfiya et al. (2018) Uncovering the fine print of the CreERT2-LoxP system while generating a conditional knockout mouse model of Ssrp1 gene. PLoS One 13:e0199785
Zhang, Dingxiao; Zhao, Shuhong; Li, Xinyun et al. (2018) Prostate Luminal Progenitor Cells in Development and Cancer. Trends Cancer 4:769-783
Hong, Chi-Chen; Sucheston-Campbell, Lara E; Liu, Song et al. (2018) Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiol Biomarkers Prev 27:321-330
Damayanti, Nur P; Budka, Justin A; Khella, Heba W Z et al. (2018) Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma. Clin Cancer Res 24:5977-5989
Mayor, Paul; Starbuck, Kristen; Zsiros, Emese (2018) Adoptive cell transfer using autologous tumor infiltrating lymphocytes in gynecologic malignancies. Gynecol Oncol 150:361-369

Showing the most recent 10 out of 1555 publications